Poland· PL-100357590

Alpicort

A prednisolone product containing prednisolonum + acidum salicylicum, registered in Poland by InPharm Sp. z o.o.. The same ATC class is registered in 4 of our 19 countries.

ATC D07XA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAlpicortATCD07XA02REGISTER NO.PL-100357590PACKS LISTED1CHECKEDSeptember 27, 2026

Where it is registered

Prednisolone is registered in 4 of 19 countries.

Countries holding a registration under ATC D07XA02 (prednisolone), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose

Prednisolone · ATC D07XA02

4 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Prednisolonum + Acidum salicylicum
Manufacturer
InPharm Sp. z o.o.
Country
Poland (PL)
ATC code
D07XA02
ATC class
Prednisolone
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991246907

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Prednisolone in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All prednisolone products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Bulgaria · Алпикорт
  • Czechia · Alpicort
  • Germany · Alpicort, Linola Akut
  • Estonia · Alpicort
  • Croatia · Alpicort
  • Hungary · Alpicort
  • Lithuania · Alpicort
  • Latvia · Alpicort
  • Slovakia · Alpicort

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e66065a6-2f5b-4120-834c-655fe3407bf1
GET /v1/drugs/e66065a6-2f5b-4120-834c-655fe3407bf1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Płyn na skórę",
  "source": "urpl",
  "strength": "(2 mg + 4 mg)/ml",
  "packaging": "05909991246907 ¦ Rp ¦ 112039\n1 butelka 100 ml",
  "substance": "Prednisolonum 2 mg/ml + Acidum salicylicum 4 mg/ml",
  "common_name": "Prednisolonum + Acidum salicylicum",
  "pl_product_id": "100357590",
  "pozwolenie_nr": "739/15",
  "auth_procedure": "IR",
  "authorisation_validity": "2030-11-03"
}

See everything about prednisolone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.